News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Francesco Maura: Why myeloma relapses after anti-CD38 antibodies
Photo taken from Francesco Maura/X
Jul 20, 2024, 21:26

Francesco Maura: Why myeloma relapses after anti-CD38 antibodies

Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center, shared a post on X:

“Happy to see our new story today on Blood Cancer Journal! We integrated Whole-genome sequencing (WGS) and immune profiling to explore why myeloma relapses after anti-CD38 antibodies.

Great collaboration with The University of Turin, The University of Milan, Sylvester Comprehensive Cancer Center, University of Miami, The National Cancer Institute of Milan and funded by AIRC Foundation for Cancer Research in Italy.

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma

Autors: Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva , Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura and Alessandra Larocca

Francesco Maura

Here is the link to this work: Kudos to all the Authors in particular Bachisio Ziccheddu, Giannotta C, Mattia D’Agostino, Massaia M, Larocca A. Thanks for this fantastic collaboration.

For more details about our findings, you can check Bachisio Ziccheddu previous twittorial.”

Source: Francesco Maura/X

 

AIRC Foundation for Cancer Research in Italy Alessandra Larocca anti-CD38 antibodies Bachisio Ziccheddu Benedetto Bruno Benjamin Diamond Blood Cancer Journal cancer Claudia Giannotta David Coffey Elisa Genuardi Elona Saraci Giuseppe Bertuglia Mario Boccadoro Marios Papadimitriou Massimo Massaia Mattia D'Agostino Niccolò Bolli Ola Landgren OncoDaily Oncology Paolo Corradini Stefania Oliva Sylvester Comprehensive Cancer Center The National Cancer Institute of Milan The University of Milan The University of Turin University of Miami Whole-genome sequencing (WGS)
Special Coverage
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network